Daiichi Sankyo, Terumo to co-develop intradermal vaccine

Under the agreement, the alliance aims to develop the first intradermal injection device in Japan to provide a more easy to use method to administer the vaccine than current methods.

The collaboration will integrate the companies respective expertise in pharmaceuticals and medical devices for innovation in vaccine.

With this agreement, the companies will further consider the wide application of the device with more types of vaccines.

Terumo plans to manufacture the intradermal device at Yamaguchi Factory, which is under construction.

Since October 2010, both the companies have been co-researching an intradermal seasonal flu vaccine.